Safa'a Al-Rais

Geschäftsführer bei Resilience Biotechnologies, Inc.

Health Technology

Profil

Safa'a Al-Rais is currently the Chief Operating Officer at Resilience Biotechnologies, Inc. Prior to this, he worked at Therapure Biopharma, Inc. from 2009 to 2020 as the Vice President-Operations.

Aktive Positionen von Safa'a Al-Rais

Unternehmen	Position	Beginn
Resilience Biotechnologies, Inc. Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi.	Geschäftsführer	-

Alle aktiven Positionen von Safa'a Al-Rais

Ehemalige bekannte Positionen von Safa'a Al-Rais

Unternehmen	Position	Ende
Therapure Biopharma, Inc. Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada.	Geschäftsführer	01.10.2020

Sehen Sie sich die Erfahrung von Safa'a Al-Rais im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Safa'a Al-Rais im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Therapure Biopharma, Inc. Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada.	Health Technology
Resilience Biotechnologies, Inc. Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi.	Health Technology